China & Manufacturing Patent Grants
We’ve achieved some exciting IP milestones for Calla Lily Clinical Care; making strong progress in building a robust IP strategy and IP portfolio to protect and advance our innovations in women’s health. 💥 China Patent Grant for our Drug Delivery Device 🌏 At long last, one of our vaginal drug delivery applications in China has …
Attending LSI USA 25
We’re delighted to be heading to Dana Point, CA during the LSI conference! From March 17th-21st, we’ll be ready to connect, collaborate, and showcase our Callavid® vaginal drug delivery innovation at one of medtech’s premier partnering events. This is an exciting opportunity to discuss new trends, potential collaborations, and meet with valued partners and industry …
The Leak Stops Here: Calla Lily Reinventing Drug Delivery for Women
University Science Center in Philadelphia, Pennsylvania highlights their CRP alum Lara in their latest Insight article: Around 23 million women worldwide experience miscarriages 𝘦𝘷𝘦𝘳𝘺 𝘺𝘦𝘢𝘳. While progesterone can reduce the risk, effective delivery remains a challenge. Frustrated with the existing, ineffective methods available, CRP alum Lara Zibners set out to create a better solution in …
Film Industry Network: Kaylie Mings discusses Women’s Health at SXSW
To coincide with the launch of this year’s SXSW, the Film Industry Network discussing women’s health with Texas native and product development engineer Kaylie Mings. Interview here: https://filmindustry.network/product-development-engineer-kaylie-mings-discusses-womens-health-at-sxsw/40570
Royal Society of Medicine’s “Innovation in Women’s Health and FemTech” Event
Last week, I had the pleasure of attending the “Innovation in Women’s Health and FemTech” event in London organised by Royal Society of Medicine. I was honored to represent Calla Lily Clinical Care at this inspiring gathering. I truly enjoyed connecting with academics, innovators, and healthcare professionals who share a passion for FemTech and improving …
Lara discussing the role of Innovation in Closing the Gender Healthcare Gap
Still buzzing from an exceptional Future of Healthtech Hub event last night hosted by THENA Capital at M&G Investments. A memorable night between the intimate crowd and superb panel of experts including Professor Dame Lesley Regan (the UK’s Women’s Health Ambassador for England), Alliott Cole, MD of Octopus Ventures (member of the Invest in Women …
SXSW Conference in Austin
Calla Lily Clinical Care is excited to be in Austin for SXSW! 🇺🇲 This dynamic conference & festival celebrates the convergence of tech, film, music, and culture while empowering creatives to achieve their goals. We’re excited to connect with like-minded innovators across these different industries who share our commitment to elevating women’s health. If you’re …
EMBAs from MIT Sloan boosting CLCC’s US strategy
We’re delighted to welcome Jaren, Humaira and TJ to our offices – three dynamic Executive MBAs from MIT Sloan School of Management who are working closely with Lara, myself and the rest of our Calla Lily Clinical Care leadership team over the next 4 months. As part of MIT Sloan’s Global Organizations action learning lab …
Sara Adam joins as MBA Strategy & Finance Intern
We are excited to welcome Sara Adam as a Strategy & Finance Intern while she pursues her MBA at London Business School! Sara brings a strong background in strategy, finance, and technology, with experience working across industries to support strategic decision-making and business growth. During her 4 years at McKinsey & Company, she led high-impact …
Panel at M&G Investments: The Role of Innovation in Closing the Gender Healthcare Gap
We’re looking forward to hearing perspectives from an esteemed panel of experts (including our co-founder Lara Zibners) on the role of innovation in Closing the Gender Healthcare Gap, hosted by THENA Capital in collaboration with M&G Investments. Lara will be sharing the stage with Professor Dame Lesley Regan – Women’s Health Ambassador for England and …